Hyderabad Telangana, India

Kasireddy Bhaskar Reddy

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Kasireddy Bhaskar Reddy

Introduction

Kasireddy Bhaskar Reddy is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target viral diseases. With a total of 2 patents to his name, Reddy's work is recognized for its potential impact on HIV treatment.

Latest Patents

Reddy's latest patents include the invention of C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors. This invention relates to pharmaceutical compositions that are useful for the therapeutic treatment of viral diseases, specifically those mediated by HIV. The innovative approach taken in these patents highlights Reddy's commitment to advancing medical science and improving treatment options for patients.

Career Highlights

Throughout his career, Reddy has worked with prominent companies in the pharmaceutical industry, including Hetero Labs Limited and Dfh Therapeutics, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Reddy has collaborated with notable coworkers such as Bandi Parthasaradhi Reddy and Gazula Levi David Krupadanam. These partnerships have further enriched his research and development efforts, leading to innovative solutions in the fight against viral diseases.

Conclusion

Kasireddy Bhaskar Reddy's contributions to the field of pharmaceuticals, particularly through his patents, demonstrate his dedication to innovation and improving healthcare outcomes. His work continues to inspire future advancements in the treatment of viral diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…